We are live on ! Find out more
PVCT.WS

PROVECTUS BIOPHARMACEUTICALS INC WTS (DE)
PVCT.WS

Delisted

PVCT.WS was delisted on the 13th of October, 2016.

Back to rankings

2 hedge funds and large institutions have $856K invested in PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) in 2015 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% less capital invested

Capital invested by funds: $1.21M → $856K (-$358K)

50% less funds holding

Funds holding: 4 → 2 (-2)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
2
Holders Change
-2
Holders Change %
-50%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$150K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$446K
2
SM
Sabby Management
Florida
-$164K
3
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$124K

PVCT.WS Hedge Fund Activity: Q3 2015 in Review

2 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) (PVCT.WS) for Q3 2015, worth a combined $856K — down 29% from $1.21M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of PVCT.WS and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was Millennium Management, opening a new position worth an estimated $150K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $446K sold.

  • 2 institutional investors held PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) (PVCT.WS) as of Q3 2015, down from 4 in Q2 2015.
  • Funds reported $856K of PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) stock for Q3 2015, down 29% quarter-over-quarter.
  • 1 fund opened new PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) positions in Q3 2015 and 3 closed out, a net change of -2 holders.
  • The largest PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) buyer in Q3 2015 was Millennium Management, an estimated $150K added.
  • The largest PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) seller in Q3 2015 was Susquehanna International Group, an estimated $446K sold.

Based on aggregated 13F filings for Q3 2015.